These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1762568)

  • 1. Protein engineering of single-chain Fv analogs and fusion proteins.
    Huston JS; Mudgett-Hunter M; Tai MS; McCartney J; Warren F; Haber E; Oppermann H
    Methods Enzymol; 1991; 203():46-88. PubMed ID: 1762568
    [No Abstract]   [Full Text] [Related]  

  • 2. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional hybrids between the variable domains of an immunoglobulin and the maltose-binding protein of Escherichia coli: production, purification and antigen binding.
    Brégégère F; Schwartz J; Bedouelle H
    Protein Eng; 1994 Feb; 7(2):271-80. PubMed ID: 8170930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP; Crowe JS
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone.
    McManus S; Riechmann L
    Biochemistry; 1991 Jun; 30(24):5851-7. PubMed ID: 2043627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a quadruplex DNA selective single-chain autoantibody from a viable motheaten mouse hybridoma with homology to telomeric DNA binding proteins.
    Brown JC; Brown BA; Li Y; Hardin CC
    Biochemistry; 1998 Nov; 37(46):16338-48. PubMed ID: 9819226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution.
    Zdanov A; Li Y; Bundle DR; Deng SJ; MacKenzie CR; Narang SA; Young NM; Cygler M
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6423-7. PubMed ID: 7517550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E; Vandevyver C; Volckaert G; Raus J
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-repetitive single-chain Fv linkers selected by selectively infective phage (SIP) technology.
    Hennecke F; Krebber C; Plückthun A
    Protein Eng; 1998 May; 11(5):405-10. PubMed ID: 9681874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and structural modeling of a single-chain Fv-asparaginase fusion protein resistant to proteolysis.
    Guo L; Wang J; Qian S; Yan X; Chen R; Meng G
    Biotechnol Bioeng; 2000 Nov; 70(4):456-63. PubMed ID: 11005928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-chain anti-DNA FV.
    Polymenis M; Stollar BD
    Methods Mol Biol; 1995; 51():265-79. PubMed ID: 7581703
    [No Abstract]   [Full Text] [Related]  

  • 15. Building antibodies from their genes.
    Hoogenboom HR; Marks JD; Griffiths AD; Winter G
    Immunol Rev; 1992 Dec; 130():41-68. PubMed ID: 1286871
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoglobulin complementarity-determining region grafting by recombinant polymerase chain reaction to generate humanised monoclonal antibodies.
    Lewis AP; Crowe JS
    Gene; 1991 May; 101(2):297-302. PubMed ID: 1905261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
    Arndt KM; Müller KM; Plückthun A
    J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and verification of hybridoma-derived monoclonal antibody variable region sequences using recombinant DNA technology and mass spectrometry.
    Babrak L; McGarvey JA; Stanker LH; Hnasko R
    Mol Immunol; 2017 Oct; 90():287-294. PubMed ID: 28865256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
    Ohage EC; Wirtz P; Barnikow J; Steipe B
    J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers.
    Dübel S; Breitling F; Fuchs P; Zewe M; Gotter S; Welschof M; Moldenhauer G; Little M
    J Immunol Methods; 1994 Sep; 175(1):89-95. PubMed ID: 7930642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.